Updated:
Veranex
Veranex is a MedTech services provider founded in 2021 in Raleigh, North Carolina. The company offers services in clinical research, commercial strategy, and...
Veranex
Veranex is a MedTech services provider founded in 2021 in Raleigh, North Carolina. The company offers services in clinical research, commercial strategy, and other areas. It serves the medical device, diagnostics, life sciences, and other industries.
General information
Firm type
Asset Manager
Year founded
2021
Location
Region
North America
Country
United States
City
Raleigh
Corporate office
Raleigh, NC, United States
Principals
David Dockhorn
Chief Executive Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Veranex?
Veranex is a growth-equity-backed operating company rather than a fund, so investment decisions are corporate strategy choices led by CEO David Dockhorn and the Board of Directors. The private equity sponsor, Summit Partners, has significant influence over capital allocation and M&A strategy. Rick Anderson, appointed Board Chairman in October 2023, brings decades of medtech commercial experience to governance decisions.
How does Veranex source business if client names are not disclosed?
The firm's business development model relies on the existing commercial relationships its six legacy companies brought to the merger in 2021. Its regulatory and clinical expertise also functions as a lead-generation tool — device companies frequently need to solve a regulatory problem before they need a new design project, and Veranex can capture both phases of the engagement.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: